NuCana PLC (NCNA)

NASDAQ HEALTHCARE
$1.91 +2.69% RSI 45 Neutral Add Alert

Moving Averages

SMA 200
$3.03
Price below

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$8.03M
P/E Ratio
0.0145
EPS
$133.4
Beta
2.176
Dividend Yield
0.00%
52-Week High
$29
52-Week Low
$1.33

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 49.0
VRTX
Vertex Pharmaceuticals Inc
RSI 56.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 49.0
MRNA
Moderna Inc
RSI 75.0
VKTX
Viking Therapeutics Inc
RSI 51.0
SRPT
Sarepta Therapeutics Inc
RSI 54.0
EDIT
Editas Medicine Inc
RSI 48.0
IOVA
Iovance Biotherapeutics Inc
RSI 50.0
NVAX
Novavax Inc
RSI 48.0

Data last updated: June 13, 2026 at 3:30 AM EDT

Track NCNA for free

Get e-mail RSI alerts when NuCana PLC enters oversold or overbought territory. Free forever.

Add Alert